Company intelligence / Profile preview

Infr

Ownership: Private
Development stage: Other

Overview

Infr is a biotechnology platform company focused on building the foundational infrastructure for modern biology. The company provides a cloud-native data management and analysis platform designed to streamline biological research and development. By integrating lab automation, high-throughput data processing, and machine learning, Infr enables scientists to manage complex biological datasets more efficiently. Its services aim to accelerate the discovery and development of new therapies by providing the "picks and shovels" necessary for data-intensive life science research.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Infr.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Infr.

Explore the full profile